SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905148-21-000072
Filing Date
2021-01-22
Accepted
2021-01-21 18:21:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc21-073_sc13d.htm SC 13D 63784
  Complete submission text file 0000905148-21-000072.txt   65659
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81613 | Film No.: 21543157
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 502-1 WANT WANT PLAZA NO. 211 SHIMEN YI ROAD JING'AN DISTRICT, SHANGHAI F4 200041
Business Address 502-1 WANT WANT PLAZA NO. 211 SHIMEN YI ROAD JING'AN DISTRICT, SHANGHAI F4 200041 862161493868
Ocumension Therapeutics (Filed by) CIK: 0001840315 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D